In this cohort study of over 50,000 women who underwent CA125 testing in English general practice, 10.1% of those with a CA125 at or above the conventional cutoff (35 U/ml) were diagnosed with ovarian cancer, and 12.3% were diagnosed with a different cancer. This evidence concerns the gene MUC16 and ovarian carcinoma.